Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

Pulmatrix reports positive results from Phase I/Ib pulmazole trial

Pulmazole is developed to treat allergic bronchopulmonary aspergillosis in patients with asthma. Credit: www.patientcaretechniciansalary.net/Michael Havens.

  • Pulmatrix

Go Top